Suppr超能文献

卵巢癌手术后住院时间延长的相关临床因素。

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery.

作者信息

Smith Christopher G, Davenport Daniel L, Gorski Justin, McDowell Anthony, Burgess Brian T, Fredericks Tricia I, Baldwin Lauren A, Miller Rachel W, DeSimone Christopher P, Dietrich Charles S, Gallion Holly H, Pavlik Edward J, van Nagell John R, Ueland Frederick R

机构信息

Department of Obstetrics & Gynecology, University of Kentucky, Lexington, KY 40536-0293, USA.

Department of Surgery, University of Kentucky, Lexington, KY 40536-0293, USA.

出版信息

Healthcare (Basel). 2019 Jul 3;7(3):85. doi: 10.3390/healthcare7030085.

Abstract

: Ovarian cancer (OC) is the leading cause of death from gynecologic malignancy and is treated with a combination of cytoreductive surgery and platinum-based chemotherapy. Extended length of stay (LOS) after surgery can affect patient morbidity, overall costs, and hospital resource utilization. The primary objective of this study was to identify factors contributing to prolonged LOS for women undergoing surgery for ovarian cancer. : The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was queried to identify women from 2012-2016 who underwent hysterectomy for ovarian, fallopian tube and peritoneal cancer. The primary outcome was LOS >50th percentile. Preoperative and intraoperative variables were examined to determine which were associated with prolonged LOS. : From 2012-2016, 1771 women underwent elective abdominal surgery for OC and were entered in the ACS-NSQIP database. The mean and median LOS was 4.6 and 4.0 days (IQR 0-38), respectively. On multivariate analysis, factors associated with prolonged LOS included: American Society of Anesthesiologists (ASA) Classification III (aOR 1.71, 95% CI 1.38-2.13) or IV (aOR 1.88, 95% CI 1.44-2.46), presence of ascites (aOR 1.88, 95% CI 1.44-2.46), older age (aOR 1.23, 95% CI 1.13-1.35), platelet count >400,000/mm (aOR 1.74, 95% CI 1.29-2.35), preoperative blood transfusion (aOR 11.00, 95% CI 1.28-94.77), disseminated cancer (aOR 1.28, 95% CI 1.03-1.60), increased length of operation (121-180 min, aOR 1.47, 95% CI 1.13-1.91; >180 min, aOR 2.78, 95% CI 2.13-3.64), and postoperative blood transfusion within 72 h of incision (aOR 2.04, 95% CI 1.59-2.62) ( < 0.05 for all). : Longer length of hospital stay following surgery for OC is associated with many patient, disease, and treatment-related factors. The extent of surgery, as evidenced by perioperative blood transfusion and length of surgical procedure, is a factor that can potentially be modified to shorten LOS, improve patient outcomes, and reduce hospital costs.

摘要

卵巢癌(OC)是妇科恶性肿瘤致死的主要原因,治疗方法为细胞减灭术和铂类化疗联合使用。手术后延长住院时间(LOS)会影响患者发病率、总体费用以及医院资源利用。本研究的主要目的是确定导致接受卵巢癌手术的女性住院时间延长的因素。

查询了美国外科医师学会国家外科质量改进计划(ACS - NSQIP)数据库,以确定2012年至2016年间因卵巢、输卵管和腹膜癌接受子宫切除术的女性。主要结局是住院时间>第50百分位数。检查术前和术中变量,以确定哪些与住院时间延长相关。

2012年至2016年间,1771名女性因OC接受了择期腹部手术,并被录入ACS - NSQIP数据库。平均住院时间和中位数住院时间分别为4.6天和4.0天(四分位间距0 - 38)。多因素分析显示,与住院时间延长相关的因素包括:美国麻醉医师协会(ASA)分级III(调整后比值比[aOR] 1.71,95%置信区间[CI] 1.38 - 2.13)或IV(aOR 1.88,95% CI 1.44 - 2.46)、存在腹水(aOR 1.88,95% CI 1.44 - 2.46)、年龄较大(aOR 1.23,95% CI 1.13 - 1.

相似文献

1
Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery.
Healthcare (Basel). 2019 Jul 3;7(3):85. doi: 10.3390/healthcare7030085.
4
Risks associated with preoperative anemia and perioperative blood transfusion in open surgery for intracranial aneurysms.
J Neurosurg. 2015 Jul;123(1):91-100. doi: 10.3171/2014.10.JNS14551. Epub 2015 Apr 10.
5
Factors affecting length of stay after elective posterior lumbar spine surgery: a multivariate analysis.
Spine J. 2015 Jun 1;15(6):1188-95. doi: 10.1016/j.spinee.2013.10.022. Epub 2013 Nov 1.
7
Neighborhood-level socioeconomic status, extended length of stay, and discharge disposition following elective lumbar spine surgery.
N Am Spine Soc J. 2022 Nov 26;12:100187. doi: 10.1016/j.xnsj.2022.100187. eCollection 2022 Dec.
9
Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8. doi: 10.1016/j.ajog.2019.02.019. Epub 2019 Feb 13.

引用本文的文献

本文引用的文献

1
Cancer statistics, 2019.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
2
Diagnosis and Treatment of Ovarian Cancer.
Hematol Oncol Clin North Am. 2018 Dec;32(6):943-964. doi: 10.1016/j.hoc.2018.07.010.
3
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Oct;16(10):1216-1247. doi: 10.6004/jnccn.2018.0078.
4
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):685-700. doi: 10.1002/jcsm.12311. Epub 2018 Jul 15.
5
Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.
Gynecol Oncol. 2018 Sep;150(3):451-459. doi: 10.1016/j.ygyno.2018.06.020. Epub 2018 Jun 29.
8
Ovarian cancer statistics, 2018.
CA Cancer J Clin. 2018 Jul;68(4):284-296. doi: 10.3322/caac.21456. Epub 2018 May 29.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验